$AVOP NEWS OUT .0002 ABOUT 2 FALL!! AV1

New Post Public Reply Private Reply Replies (1) Message Board
Compensated Post
pennybuster
$AVOP NEWS OUT .0002 ABOUT 2 FALL!!







AV1 Group Announces Television101's Selection of VaporHighUSA.com as Preferred Target for Its Upcoming Shows‏

Jan 20, 2015 (ACCESSWIRE via COMTEX) -- LA JOLLA, CA / ACCESSWIRE / January 20, 2014 / AV1 Group,Inc. (OTC Pink: AVOP), is pleased to announce that in accordance with its recently announced relationship with television 101 of Hollywood California, VaporHighUSA has been selected to be the first subsidiary to participate in tv101's indirect marketing strategy.‏

Av1 Group is actively exploring creative advertising opportunities which, in collaboration with television 101, are expected to exponentially increase vaporhighusa.com's visibility. "This year we expect to set numerous projects in motion with tv101, and we believe that this endorsement is a stamp of approval for VaporHighUSA and its choice product line. With keen attention to sharp aesthetics, first-rate products and premium customer service, we expect www.vaporhighusa.com to become a strong competitor in this fast growing segment," stated Bryen Beglinger, the CEO of AV1 Group Inc.

The Company expects that numerous announcements will be forthcoming in the near future in regards to VaporHigh's aggressive strategy to gain exposure for the Company and its products.

Indirect marketing is a strategically designed advertising model that integrates the products and brands being advertised with the programming that viewers enjoy in a relaxed and receptive state. It's a fully researched and proven method for a business to market their product, concept, or service without having to use a direct approach which results in a passive yet often more successful reception according to research.

"We at television101 are very pleased with VaporHighUSA.com, and are excited about the ongoing possibilities. With media product placement leading the way in effective branding, and the unique quality of VaporHigh's products, we believe the potential here is outstanding," stated Jeff Orsa, Producer, Partner, Director and Cinematographer of Television 101.

As recently announced, the Company has been made eligible for book-entry delivery and depository services of The Depository Trust Company (the "DTC" to facilitate electronic settlement and transfer of its common shares.

Management is resolute on establishing a good position in this industry as the markets continue to open. The revenue generating potential of this Company is consequently expected to be considerably strengthened in this growing market that has demonstrated a potentially explosive probability to flourish.

About VaporHighUSA.com:

VaporHighUSA.com was launched in 2014 with the objective of creating an educational destination to serve and empower members that would showcase and sell the Company's new revolutionary select product line; offering the latest in vaping technology at very competitive pricing.For more information Visit: www.VaporHighUSA.com.

About Television 101:

Television 101, recently acquired under an asset purchase agreement by Strategic Global inc., consists of an eclectic team of skilled writers, directors, producers, cinematographers, and editors that develop and produce cutting edge film, television shows, and commercial spots that are compelling, entertaining, and at times amusing. Projects currently in production or development are Academy Award nominated screenwriter, Krzysztof Kieslowski Documentary feature, Krzysztof Piesiewicz's "Love", a drama feature, "Reel Guerrillas" a comedy feature, Television series, "Greed,", "Two Dope Detectives", "Granola Heads" |"No Man's Land," and "Rebecca's Coast," a variety of television pilots (both scripted and documentary/reality), long and short form commercial productions, and multimedia/internet programming. television 101 LLC is a Limited Liability Company and is headquartered in Hollywood, California. For more information visit: http://www.television101.net/what.html.

About AV1 Group, Inc.

Group, Inc. is a publicly traded investment and holding company established to identify, secure, and monetize emerging growth companies in a number of sectors that include cannabis related technologies and ecommerce businesses positioned for exponential growth.

The Company seeks to discover inspired entrepreneurs with revolutionary concepts which can make a substantial footprint in markets that the Company believes to have exponential growth potential. AV1 Group, Inc.'s comprehensive business model also includes a division which delivers internally created projects that are poised for revenue generation, and a platform enabling the Company to develop embryonic stage subsidiaries under one umbrella, bringing a spectrum of backgrounds to the table, thus providing a significant resource of experience, knowledge and expertise to every venture. AV1 Group, Inc. explores every opportunity to help each sector exceed their revenue goals while building close, active working relationships; preparing each respective division to be a robust competitor in their chosen markets. For more information visit: http://www.av1group.com/.

Safe Harbor Act: Forward-Looking

Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

For Investor Relations Please Call: 844-763-5848 or email us at info@AV1Group.com

SOURCE: AV1 Group,Inc.

http://www.accesswire.com/img.ashx?id=425010

Copyright 2015 ACCESSWIRE

disclaimer:
http://alturl.com/wysjh
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading